跳至主要内容
临床试验/NCT01810627
NCT01810627已完成不适用

Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma

William St Clair1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
Change in prostate volume measured in cm^3

研究概览

简要总结

This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male 50-80 years of age Eligible for interstitial brachytherapy implants

排除标准

  • 未提供

结局指标

主要结局

Change in prostate volume measured in cm^3

时间窗: One month post implant

Change in prostate volume measured with trans-rectal ultrasound at baseline versus prostate volume measured with KVCT and MVCT.

次要结局

未报告次要终点

研究者

发起方
William St Clair
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

William St Clair

Faculty, Radiation Medicine

University of Kentucky

研究点 (1)

Loading locations...

相似试验

Application of Megavoltage Imaging to Reduce... | 临床试验